Glooko’s integration of Hedia’s diabetes tech aims to improve care for patients and enhance healthcare provider insights.

Glooko, Inc. and Hedia, today announced the launch of their interoperable solution, which combines connected care, remote ...

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. Glooko, Inc. and Hedia today announced the launch ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

AiRANACULUS®, a private, Massachusetts-based technology company providing state-of-the-art Artificial Intelligence (AI) and Machine Learning (ML) solutions, has been awarded a two-year contract to ...

Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, today announced the closing of an oversubscribed ?65 million Series ...

"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

Political leaders have shunned the Alternative for Germany. But on his social media platform X, Mr. Musk is pitching the party as mainstream. By Jim Tankersley Pierre Poilievre, the Conservative ...